Kevin Lillehei, MD
Affiliations: | 2003- | Neurosurgery | University of Colorado Anschutz Medical Campus, Denver, Aurora, CO |
Google:
"Kevin Lillehei"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kleinschmidt-DeMasters B, Rosenblum M, Kerr J, et al. (2019) RARE-02. SYMPTOMATIC SALIVARY GLAND-LIKE TUMORS OF THE SELLAR REGION: ADDITIONAL FEATURES AND REVIEW OF THE LITERATURE Neuro-Oncology. 21: vi221-vi221 |
| Harland TA, Freeman JL, Davern M, et al. (2017) Progesterone-only contraception is associated with a shorter progression-free survival in premenopausal women with WHO Grade I meningioma. Journal of Neuro-Oncology |
| Lillehei K, Davies K, Aisner D, et al. (2016) RARE-43. SEARCH FOR DRUGGABLE TARGETS IN PRIMARY NERVOUS SYSTEM MELANOTIC TUMORS: MELANOCYTOMAS, MELANOTIC SCHWANNOMAS, PRIMARY MELANOMAS Neuro-Oncology. 18: vi169-vi169 |
| Ryken T, Scullin E, Smith K, et al. (2016) Actr-48. A Multicenter, 500-Patient, Prospective Observational Registry Of The Performance Of Carmustine Wafers For Cns Malignancies Neuro-Oncology. 18 |
| Carlson JA, Reddy K, Gaspar LE, et al. (2015) Hypofractionated-intensity modulated radiotherapy (hypo-IMRT) and temozolomide (TMZ) with or without bevacizumab (BEV) for newly diagnosed glioblastoma multiforme (GBM): a comparison of two prospective phase II trials. Journal of Neuro-Oncology. 123: 251-7 |
| Ney D, Kleinschmidt-DeMasters BK, Carlson J, et al. (2014) RT-24 * EXTENT OF CEREBRAL RADIONECROSIS IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM) TREATED ON A CLINICAL TRIAL WITH HYPOFRACTIONATED INTENSITY-MODULATED RADIATION THERAPY (HYPO-IMRT) COMBINED WITH TEMOZOLOMIDE (TMZ) AND BEVACIZUMAB (BEV) Neuro-Oncology. 16: v192-v192 |
| Reddy K, Damek D, Gaspar LE, et al. (2012) Phase II trial of hypofractionated IMRT with temozolomide for patients with newly diagnosed glioblastoma multiforme. International Journal of Radiation Oncology, Biology, Physics. 84: 655-60 |
| Fields EC, Damek D, Gaspar LE, et al. (2012) Phase I dose escalation trial of vandetanib with fractionated radiosurgery in patients with recurrent malignant gliomas. International Journal of Radiation Oncology, Biology, Physics. 82: 51-7 |
| Reddy K, Damek D, Gaspar LE, et al. (2012) Hypofractionated Intensity Modulated Radiation Therapy Altered Patterns of Failure in Patients With Glioblastoma Multiforme Treated on a Phase II Trial International Journal of Radiation Oncology Biology Physics. 84 |
| Chen C, Damek D, Gaspar LE, et al. (2011) Phase I trial of hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy for patients with newly diagnosed glioblastoma multiforme. International Journal of Radiation Oncology, Biology, Physics. 81: 1066-74 |